Seres Therapeutics, Inc.MCRBNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower, above historical average, structural decline.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-6.16%
↑ 87% above average
Average (9y)
-48.22%
Historical baseline
Range
High:61.62%
Low:-404.17%
CAGR
-37.2%
Structural decline
| Period | Value |
|---|---|
| 2024 | -6.16% |
| 2023 | 61.62% |
| 2022 | -223.67% |
| 2021 | 35.98% |
| 2020 | 9.96% |
| 2019 | 48.91% |
| 2018 | -9.90% |
| 2017 | 3.93% |
| 2016 | 1.29% |
| 2015 | -404.17% |